Tag: Multiple Sclerosis
Plasma NfL Level Tied to Risk for Disability in Multiple Sclerosis
High pNfL levels linked to increased adjusted rates of Expanded Disability Status Scale worsening
Low Vitamin D, Smoking Predict Worse Cognitive Function in MS
Higher vitamin D predicted better cognitive performance, while smoking predicted worse performance
Risk Score Can Predict Long-Term Multiple Sclerosis Progression
Secondary progression score based on five clinical risk factors
Brain Changes From Multiple Sclerosis May Occur in Preteens
Greater genetic predisposition for MS tied to imaging-observable changes in white matter in preteens
Multisensor Data Can Assess MS-Related Limb Dysfunction
Extracted features from three sensors correlate with physician-rated, patient-reported disability status
Patients Report Cannabis Eases Spasticity in Multiple Sclerosis
More than one-third of MS patients with spasticity report current cannabis use
Age of Onset May Affect Clinical Outcomes for MS Patients on DMT
Age-dependent differences seen for clinical outcomes in response to disease-modifying therapy
Early Treatment Tied to Less Disability With Pediatric-Onset MS
Less disability seen among those initiating disease-modifying therapy within two years of clinical onset
Comorbidities Tied to Higher Rates of All-Cause Admissions in MS Patients
But comorbidities not associated with increased hospitalizations related to multiple sclerosis
2011 to 2017 Saw Increase in Spending on DMTs for MS
Increase in annual expenditures on MS DMTs mainly driven by increases in per-prescription costs
